Department: Office of Research


News

Clinical Trials Network Successful in Bringing Significant Trials to UTHSC, COVID-19 Therapeutics Trial the Latest

|

The Clinical Trials Network of Tennessee (CTN2) at the University of Tennessee Health Science Center has contracted a new clinical trial to test possible therapeutics for COVID-19 in hospitalized patients. This new trial brings the total generated by CTN2 contracts for the university to nearly $7 million. Since its launch in 2018, CTN2 has brought… Read More


News

UTHSC’s Byron Jones Receives $2.87 Million For Gulf War Illness Study

|

The National Institute of Environmental Health Sciences has awarded Byron C. Jones, PhD, professor in the Department of Genetics, Geonomics, and Informatics at the University of Tennessee Health Science Center, $2.87 million for his continuing study of genetic alterations associated with Gulf War illness among former military personnel. During the 1990-91 Gulf War, 700,000 troops… Read More


News

UTHSC Team Receives $2 Million For Diabetes Pathophysiology Study

|

The National Institute of Diabetes and Digestive and Kidney Diseases recently awarded a team of UTHSC researchers $1.99 million for their work to advance understanding of the pathophysiology of prediabetes, diabetes, and related complications. Sam Dagogo-Jack, MD, professor of Medicine and director of the General Clinical Research Center, is a principal investigator, along with Nawajes… Read More


News

UTHSC, UAB Collaborate on $2.39 Million Research Network

|

The University of Tennessee Health Science Center and the University of Alabama at Birmingham (UAB) Minority Health and Health Disparities Research Center have received a $2.39 million grant to create the Emotional Well-being and Economic Burden Research Network (EMOT-ECON). The award is from the National Center for Complementary and Integrative Health and the National Institutes of… Read More


News

UTHSC’s Jonathan Wall Receives $1.79 Million To Develop New Amyloidosis Treatment

|

The National Institute of Diabetes and Digestive and Kidney Diseases recently awarded Jonathan Wall, PhD, professor in the University of Tennessee Health Science Center’s Graduate School of Medicine in Knoxville, a $1.79 million grant for his study titled “Developing a Theranostic Immunotherapy for Systemic Amyloidosis.” Amyloidosis is a rare disease that occurs when abnormal protein… Read More


News

Dr. Jonathan Jaggar Receives $2.3 Million For Blood Pressure Research

|

The National Heart, Lung, and Blood Institute recently awarded Jonathan H. Jaggar, PhD, Maury Bronstein Endowed Professor in the Department of Physiology at the University of Tennessee Health Science Center (UTHSC), a $2.3 million grant for his study titled “PKD proteins in endothelial cells.” The proposal’s goal is to provide a new understanding of how… Read More


News

Drs. Francesca-Fang Liao, Fu-Ming Zhou Receive $1.9 Million to Study Possible Dementia Causes

|

The National Institute of Neurological Disorders and Stroke has awarded two UTHSC researchers over $1.9 million to study the pathogenesis of white matter damage, a main contributing factor to dementia. Francesca-Fang Liao, PhD, and Fu-Ming Zhou, PhD, both professors in the Department of Pharmacology, Addiction Science, and Toxicology, are co-investigators on the project titled “Blood-brain-barrier… Read More


News

UTHSC’s Vaithianathan Receives $1.9 Million Grant for Retinal Research

|

Thirumalini Vaithianathan, PhD, assistant professor in the Department of Pharmacology, Addiction Science, and Toxicology at the University of Tennessee Health Science Center, has spent a decade studying molecular signaling involved in vision. She has just received $1.9 million from the National Eye Institute for her project titled, “Dynamics of calcium signals control neurotransmitter release in… Read More